| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 358.27M | 379.96M | 368.69M | 371.52M | 350.92M |
| Gross Profit | 85.91M | 92.12M | 92.99M | 87.34M | 86.97M |
| EBITDA | 90.40M | 101.04M | 105.22M | 106.95M | 108.39M |
| Net Income | -5.43M | 14.45M | -5.29M | 23.01M | 25.54M |
Balance Sheet | |||||
| Total Assets | 453.26M | 455.22M | 439.96M | 469.37M | 464.47M |
| Cash, Cash Equivalents and Short-Term Investments | 21.27M | 12.67M | 6.06M | 11.14M | 13.62M |
| Total Debt | 233.84M | 216.59M | 193.24M | 204.03M | 201.86M |
| Total Liabilities | 322.14M | 304.82M | 286.94M | 294.44M | 297.88M |
| Stockholders Equity | 131.12M | 150.40M | 153.02M | 174.93M | 166.59M |
Cash Flow | |||||
| Free Cash Flow | 2.19M | 7.07M | 17.31M | 3.00M | 8.03M |
| Operating Cash Flow | 61.40M | 80.74M | 89.64M | 66.31M | 76.71M |
| Investing Cash Flow | -35.72M | -59.87M | -47.06M | -38.46M | -53.55M |
| Financing Cash Flow | -31.28M | -13.88M | -47.63M | -30.49M | -25.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £217.67M | 12.04 | 35.67% | 5.18% | 0.73% | 7.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
50 Neutral | £181.72M | -37.27 | -3.89% | 7.52% | -5.71% | -137.57% | |
50 Neutral | £1.06B | 1.01 | 7.58% | 714.29% | ― | ― | |
46 Neutral | £95.96M | -3.47 | -19.68% | 8.43% | -0.12% | -2304.17% | |
42 Neutral | £24.92M | -0.17 | -89.16% | ― | ― | ― |